AKPENTOLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akpentolate, and what generic alternatives are available?
Akpentolate is a drug marketed by Rising and is included in two NDAs.
The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Summary for AKPENTOLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 1,236 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AKPENTOLATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AKPENTOLATE
US Patents and Regulatory Information for AKPENTOLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | AKPENTOLATE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040164-001 | Jan 13, 1997 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Rising | AKPENTOLATE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040165-001 | Jan 13, 1997 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |